✦ LIBER ✦

A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer

✍ Scribed by Lana E Kandalaft, Daniel J Powell Jr, George Coukos

Book ID: 119905228
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 541 KB
Volume: 10
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-10-157

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial results of a folate recept

Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence

✍ Byrd, K.A.; Schneble, E.; Ponniah, S.; McGuire, W.P.; Conrads, T.P.; Elkas, J.C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 121 KB

RIBBON-1: Randomized, Double-Blind, Plac

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer

✍ Robert, N. J.; Dieras, V.; Glaspy, J.; Brufsky, A. M.; Bondarenko, I.; Lipatov, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 317 KB